Alyeska Investment Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-196,752
Closed -$767K 566
2018
Q1
$767K Buy
+196,752
New +$767K 0.01% 372
2017
Q3
Sell
-466,529
Closed -$1.54M 573
2017
Q2
$1.54M Buy
+466,529
New +$1.54M 0.01% 348
2016
Q3
Sell
-78,949
Closed -$268K 573
2016
Q2
$268K Buy
78,949
+1,602
+2% +$5.44K ﹤0.01% 402
2016
Q1
$411K Buy
77,347
+2,347
+3% +$12.5K ﹤0.01% 359
2015
Q4
$923K Buy
+75,000
New +$923K 0.01% 335